Impact Stories

Filter:

McGill and RI-MUHC team partnering with National Research Council has obtained funding from Innovation, Science, and Economic Development Canada to

SARS-CoV-2 has shut down the world by spreading furiously from one person to another. Now scientists want to trace its steps within cells to stop it.

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

Evidence reviews of masks, goggles and shoe covers suggest individual pieces of personal protective equipment aren’t enough by themselves to protect health worke

Partnerships like this one can dramatically accelerate efforts to move research from lab to community, says virologist.

This content is available in French only.